Structural and kinetic basis for heightened immunogenicity of T cell vaccines.
Analogue peptides with enhanced binding affinity to major histocompatibility class (MHC) I molecules are currently being used in cancer patients to elicit stronger T cell responses. However, it remains unclear as to how alterations of anchor residues may affect T cell receptor (TCR) recognition. We...
المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2005
|